N/A
Completed N=481
Efficacy of the Female Athlete Body Project (FAB)
Source: ClinicalTrials.gov NCT01735994 ↗Enrolled (actual)
481
Serious AEs
0.0%
Results posted
Dec 2019
Primary outcomePrimary: Eating Disorder Examination Questionnaire (EDE-Q) — .98; 1.24; .54; .84 units on a scale
Summary
Given the cost of treating eating disorders and the substantial morbidity and mortality associated with these disorders, prevention of eating disorders has considerable public health significance. Female athletes represent an important population for prevention due to their risk for the Female Athlete Triad, which includes inadequate energy intake, irregular or cessation of menses, and osteoporosis. The proposed randomized controlled trial will provide important information regarding the efficacy, acceptability, and feasibility of implementing a brief eating disorder prevention and healthy living program within an existing social system of female athletes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Eating Disorder Examination Questionnaire (EDE-Q) |
.98; 1.24; .54; .84; 1.13; 1.46 | — |
| PRIMARY Number of Subjective and Objective Binge Episodes as Measured by the Eating Disorder Examination Questionnaire (EDE-Q) |
.35; .63; .49; .57 | — |
| SECONDARY Secondary Outcomes |
2.46; 2.71; 30.28; 29.87; 3.20; 3.43 | — |
| SECONDARY Secondary Outcomes - BMI |
25.09; 24.22 | — |
Eligibility Criteria
Inclusion Criteria
- Female
- Member of a University-sponsored athletic team,
- Are willing and able to provide informed consent, attend all study visits, and comply with the study protocol
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT01735994). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.